Senores Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

502.85

-28.35 (-5.34%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

502.85

-28.35 (-5.34%)
16:10 Jan 10

Quality

0/100
Not Eligible

Valuation

3/100
Expensive Valuation

Technical

0/100
Technically Bearish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2022	Mar 2023	Mar 2024
Net Sales	14.17	35.34	214.52
Operating Expenses +	12.23	22.66	172.93
Raw Material	10.43	13.24	102.26
Increase Decrease in Cost	-2.4	-0.48	3.88
Other Manufacturing Expense	0	0	0
Employee Cost	2.86	4.79	35.46
Miscellaneous Expenses	22.2	30.91	171.93
Operating Profit	1.94	12.68	41.59
Other Income	0.46	3.68	2.82
Depreciation	0.7	1.78	10.02
Interest	0.56	2.14	9.45
Profit before tax and exceptio..	1.14	12.44	24.94
Exceptional Items	0	0	0
PBT	1.14	12.44	24.94
Provision for Taxation	0.15	4	-7.76
Net Profit	0.99	8.43	32.71
NET Profit after MI	0.99	8.43	31.46
EPS	1.81	8.87	13.67
Operating Profit Margin (%)	13.69	35.88	19.39
Net Profit Margin (%)	6.99	23.85	14.67